Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

EXtensive mulTilayer stEnt treatmeNt in Aortic disSectiOn

NCT: NCT06675617 · RECRUITING

NCT IDNCT06675617
StatusRECRUITING
Start Date2024-10-30
Completion2031-06
SponsorIntressa Vascular SA (INDUSTRY)
First posted
Last updated

Brief Summary

This clinical trial is a prospective, multicenter, open label study designed to evaluate the effectiveness and the safety of the Allay® Aortic Stent as adjunctive endovascular treatment of Type B aortic dissection in patients eligible for thoracic endovascular aortic repair with stent grafts.

Frequently Asked Questions

What is EXtensive mulTilayer stEnt treatmeNt in Aortic disSectiOn?

EXtensive mulTilayer stEnt treatmeNt in Aortic disSectiOn is a clinical trial registered under NCT06675617. Current status: RECRUITING.

What is the status of NCT06675617?

The current status of NCT06675617 (EXtensive mulTilayer stEnt treatmeNt in Aortic disSectiOn) is: RECRUITING.

When did EXtensive mulTilayer stEnt treatmeNt in Aortic disSectiOn start?

EXtensive mulTilayer stEnt treatmeNt in Aortic disSectiOn started on 2024-10-30.

Related Devices

PMA P150028Aortic stentNuMED, Inc. PMA P240003Aortic stentRenata Medical, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑